AGC Biologics

Mark Womack, Chief Business Officer
Seattle, WA
(OTCMKTS: ASGLY)
Right. On Time. AGC Biologics is a leading global Contract Development and Manufacturing Organization (CDMO), providing world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), viral vectors, and genetically engineered cells. The company’s commitment to continuous innovation fosters the technical creativity to solve clients’ most complex challenges, including specialization in fast track projects for orphan drugs and rare diseases. www.agcbio.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions